What genetic SNPs are associated with Steatorrhea?

Steatorrhea, also known as fatty stool or malabsorption, is a common symptom of several chronic digestive conditions including celiac disease, cystic fibrosis, and inflammatory bowel disease. It is characterized by the presence of high amounts of fat in the stools due to improper digestion and absorption in the small intestine.

Research has associated certain single-nucleotide polymorphisms (SNPs) with an increased risk for steatorrhea. A study conducted on genetic variants related to lipid metabolism found that SNPs such as rs7865160 located on chromosome 4p16 were risk factors for both cystic fibrosis-related steatorrhea and non-cystic fibrosis related steatorrhea.

Other SNPs such as rs2268936 located on chromosome 1q24 have been linked to poor response from therapeutic enzymes used to treat pancreatic insufficiency due to a variety of different conditions including cystic fibrosis and Crohn’s Disease – both known causes of steatorrhea.

Yet another SNP found within ten centimorgan region around rs11803731 located near the PLTP gene has been associated with an increased risk for developing steatorrhea when combined with other genomic events causing dysfunction in lipoprotein production or processing.

Overall, there are many different single nucleotide polymorphisms that can contribute to an individual's predisposition toward developing Steatarrhrea with some being more strongly correlated than others depending on each patient's individual gene makeup. As research into this topic continues, it may be possible one day soon identify those at higher risk before symptoms develop which could lead to improved treatment options for individuals dealing with this condition.